
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $254.7M | -- | -- | $1.68 | -- |
08/06/2025 | Q2 | $240.9M | -- | -- | $1.38 | -- |
05/06/2025 | Q1 | $287.2M | $289.3M | $2.52 | $2.51 | $0.01 |
02/19/2025 | Q4 | $289.6M | $292.6M | $2.84 | $2.94 | -$0.10 |
11/06/2024 | Q3 | $239.7M | $238.3M | $1.42 | $1.47 | -$0.05 |
08/06/2024 | Q2 | $223.6M | $227.5M | $1.19 | $1.10 | $0.09 |
05/07/2024 | Q1 | $272.4M | $274.7M | $2.29 | $2.22 | $0.07 |
02/13/2024 | Q4 | $275.2M | $278.3M | $2.70 | $2.72 | -$0.02 |
11/02/2023 | Q3 | -- | -- | $1.19 | $1.09 | $0.10 |
08/03/2023 | Q2 | -- | -- | $0.96 | $0.89 | $0.07 |
05/02/2023 | Q1 | -- | -- | $1.94 | $1.96 | -$0.02 |
02/16/2023 | Q4 | -- | -- | $2.30 | $2.24 | $0.06 |
10/27/2022 | Q3 | -- | -- | $0.96 | $0.87 | $0.09 |
08/04/2022 | Q2 | -- | -- | $0.80 | $0.84 | -$0.04 |
05/04/2022 | Q1 | -- | -- | $1.66 | $1.70 | -$0.04 |
02/16/2022 | Q4 | -- | -- | $2.15 | $2.11 | $0.04 |
10/28/2021 | Q3 | -- | -- | $1.08 | $1.14 | -$0.06 |
08/05/2021 | Q2 | -- | -- | $1.09 | $1.09 | -- |
05/05/2021 | Q1 | -- | -- | $1.69 | $1.67 | $0.02 |
02/17/2021 | Q4 | -- | -- | $1.86 | $1.79 | $0.07 |
11/05/2020 | Q3 | -- | -- | $1.11 | $1.11 | $0.00 |
08/04/2020 | Q2 | -- | -- | $1.00 | $0.89 | $0.11 |
05/07/2020 | Q1 | -- | -- | $1.49 | $1.50 | -$0.01 |
02/19/2020 | Q4 | -- | -- | $1.59 | $1.54 | $0.05 |
11/06/2019 | Q3 | -- | -- | $1.20 | $1.15 | $0.05 |
08/06/2019 | Q2 | -- | -- | $1.06 | $0.94 | $0.12 |
05/07/2019 | Q1 | -- | -- | $1.59 | $1.50 | $0.10 |
02/20/2019 | Q4 | -- | -- | $1.57 | $1.42 | $0.16 |
11/08/2018 | Q3 | -- | -- | $1.06 | $0.99 | $0.07 |
08/08/2018 | Q2 | -- | -- | $0.98 | $0.85 | $0.13 |
05/02/2018 | Q1 | -- | -- | $1.53 | $1.39 | $0.14 |
02/21/2018 | Q4 | -- | -- | $1.19 | $1.10 | $0.09 |
11/01/2017 | Q3 | -- | -- | $0.85 | $0.75 | $0.10 |
08/01/2017 | Q2 | -- | -- | $0.83 | $0.68 | $0.15 |
05/04/2017 | Q1 | -- | -- | $1.16 | $1.01 | $0.15 |
02/16/2017 | Q4 | -- | -- | $1.02 | $0.98 | $0.04 |
11/02/2016 | Q3 | -- | -- | $0.67 | $0.59 | $0.08 |
08/04/2016 | Q2 | -- | -- | $0.59 | $0.54 | $0.05 |
05/09/2016 | Q1 | -- | -- | $0.92 | $0.88 | $0.04 |
02/17/2016 | Q4 | -- | -- | $0.81 | $0.78 | $0.03 |
10/28/2015 | Q3 | -- | -- | $0.70 | $0.65 | $0.05 |
Grand Canyon Education reported $289.3M worth of top line sales in its most recent quarter.
Grand Canyon Education announced earnings per share of $2.52 which represents a beat of analyst forecast a $2.51 per share.
Grand Canyon Education reported $160.8M that represents $5.65 per share over the last quarter.
Grand Canyon Education's earnings are forecast to grow from $7.73 per share to $8.03 per share next year representing an increase of 13.67%.
Grand Canyon Education's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.